Incyte News

Incyte's Strategic Acquisition and Promising Pipeline Secure Buy Rating

TipRanksApr 26 02:16 ET

Oppenheimer Sticks to Its Buy Rating for Incyte (INCY)

TipRanksApr 24 07:46 ET

Incyte Analyst Ratings

BenzingaApr 24 07:21 ET

Incyte Acquisition Strategy and Drug Pipeline Evaluation: A Hold Recommendation

TipRanksApr 24 05:35 ET

Incyte (INCY) Gets a Buy From Piper Sandler

TipRanksApr 23 15:25 ET

Incyte Analyst Ratings

BenzingaApr 23 07:59 ET

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), BioMarin Pharmaceutical (BMRN) and ACADIA Pharmaceuticals (ACAD)

TipRanksApr 8 22:40 ET

Incyte Analyst Ratings

BenzingaMar 25 10:25 ET

RBC Capital Sticks to Its Hold Rating for Incyte (INCY)

TipRanksMar 24 21:48 ET

Analysts Are Bullish on Top Healthcare Stocks: Biote (BTMD), Incyte (INCY)

TipRanksMar 13 07:40 ET

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Incyte (INCY)

TipRanksMar 13 06:50 ET

Incyte's Hold Rating: Balancing Clinical Promise Against Financial and Market Position

TipRanksMar 13 00:25 ET

Incyte Analyst Ratings

BenzingaMar 12 11:13 ET

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), AnaptysBio (ANAB) and ITeos Therapeutics (ITOS)

TipRanksMar 12 06:40 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Fortrea Holdings Inc. (FTRE) and Abbott Labs (ABT)

TipRanksMar 12 05:20 ET

Incyte's Growth Potential Weighed Against Upcoming Challenges: A Hold Rating Analysis

TipRanksMar 11 07:08 ET

Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Insmed (INSM)

TipRanksMar 5 07:40 ET

Incyte Analyst Ratings

BenzingaFeb 23 05:52 ET

Analysts Conflicted on These Healthcare Names: Incyte (INCY), Gilead Sciences (GILD) and Shockwave Medical (SWAV)

TipRanksFeb 16 08:00 ET

Incyte Corporation: A Hold Recommendation Amidst Modest Growth and Pipeline Developments

TipRanksFeb 15 02:55 ET